LMR Partners’s T2 Biosystems, Inc TTOO Stock Holding History

LMR Partners’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18	Closed	-$150K	–	1377
2021 Q1	$150K	Buy	18 +15	+500%	+$159K	﹤0.01%	815
2020 Q4	$16K	Buy	+3	New	+$18.4K	﹤0.01%	477
2019 Q4	–	Sell	-8	Closed	-$103K	–	583
2019 Q3	$103K	Hold	8	–	–	0.01%	359
2019 Q2	$69K	Buy	+8	New	+$93.7K	﹤0.01%	370
2017 Q3	–	Sell	-11	Closed	-$180K	–	584
2017 Q2	$180K	Buy	+11	New	+$220K	0.01%	533

Other funds holding TTOO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KFS

Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

LMR Partners's TTOO Position: Q2 2021 in Review

LMR Partners sold out of T2 Biosystems, Inc (TTOO) in Q2 2021, closing a stake of 18 shares — an estimated $150K sold.

LMR Partners first reported a position in TTOO in Q2 2017 and held it in 5 quarters. The position peaked at $180K in Q2 2017. 78 funds tracked by Wall St. Rank hold TTOO as of Q2 2021.

LMR Partners reported no remaining T2 Biosystems, Inc position as of Q2 2021 after selling out during the quarter.
LMR Partners sold 18 T2 Biosystems, Inc shares in Q2 2021, an estimated $150K.
LMR Partners first reported a position in T2 Biosystems, Inc in Q2 2017 and held it in 5 quarters.
LMR Partners's T2 Biosystems, Inc position peaked at $180K in Q2 2017.
78 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2021.

Based on LMR Partners's 13F filing for Q2 2021, filed 16 Aug 2021.